SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000078003-23-000104
Filing Date
2023-10-25
Accepted
2023-10-25 17:29:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A ALLOGENE THERAPEUTICS sch13d_allox1023.htm SC 13D/A 67544
  Complete submission text file 0000078003-23-000104.txt   69169
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90685 | Film No.: 231346943
SIC: 2836 Biological Products, (No Diagnostic Substances)